The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Open-Angle Glaucoma Therapeutics Market Research Report 2025
Synopsis
Glaucoma is a group of eye diseases which result in damage to the optic nerve and cause vision loss.
The global Open-Angle Glaucoma Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Open-Angle Glaucoma Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Open-Angle Glaucoma Therapeutics.
Report Scope
The Open-Angle Glaucoma Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Open-Angle Glaucoma Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Open-Angle Glaucoma Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aerie Pharmaceuticals Inc.
Allergan Plc
Bausch Health Companies, Inc.
Novartis AG
Pfizer Inc.
Segment by Type
Prostaglandin Analogs (PGAs)
Combination of PGAs
Other
Segment by Application
Hospital
Clinic
Research Institute
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Open-Angle Glaucoma Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Glaucoma is a group of eye diseases which result in damage to the optic nerve and cause vision loss.
The global Open-Angle Glaucoma Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Open-Angle Glaucoma Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Open-Angle Glaucoma Therapeutics.
Report Scope
The Open-Angle Glaucoma Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Open-Angle Glaucoma Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Open-Angle Glaucoma Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aerie Pharmaceuticals Inc.
Allergan Plc
Bausch Health Companies, Inc.
Novartis AG
Pfizer Inc.
Segment by Type
Prostaglandin Analogs (PGAs)
Combination of PGAs
Other
Segment by Application
Hospital
Clinic
Research Institute
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Open-Angle Glaucoma Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Open-Angle Glaucoma Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Prostaglandin Analogs (PGAs)
1.2.3 Combination of PGAs
1.2.4 Other
1.3 Market by Application
1.3.1 Global Open-Angle Glaucoma Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Open-Angle Glaucoma Therapeutics Market Perspective (2019-2030)
2.2 Open-Angle Glaucoma Therapeutics Growth Trends by Region
2.2.1 Global Open-Angle Glaucoma Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Open-Angle Glaucoma Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Open-Angle Glaucoma Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Open-Angle Glaucoma Therapeutics Market Dynamics
2.3.1 Open-Angle Glaucoma Therapeutics Industry Trends
2.3.2 Open-Angle Glaucoma Therapeutics Market Drivers
2.3.3 Open-Angle Glaucoma Therapeutics Market Challenges
2.3.4 Open-Angle Glaucoma Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Open-Angle Glaucoma Therapeutics Players by Revenue
3.1.1 Global Top Open-Angle Glaucoma Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Open-Angle Glaucoma Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Open-Angle Glaucoma Therapeutics Revenue
3.4 Global Open-Angle Glaucoma Therapeutics Market Concentration Ratio
3.4.1 Global Open-Angle Glaucoma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Open-Angle Glaucoma Therapeutics Revenue in 2023
3.5 Open-Angle Glaucoma Therapeutics Key Players Head office and Area Served
3.6 Key Players Open-Angle Glaucoma Therapeutics Product Solution and Service
3.7 Date of Enter into Open-Angle Glaucoma Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Open-Angle Glaucoma Therapeutics Breakdown Data by Type
4.1 Global Open-Angle Glaucoma Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Open-Angle Glaucoma Therapeutics Forecasted Market Size by Type (2025-2030)
5 Open-Angle Glaucoma Therapeutics Breakdown Data by Application
5.1 Global Open-Angle Glaucoma Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Open-Angle Glaucoma Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Open-Angle Glaucoma Therapeutics Market Size (2019-2030)
6.2 North America Open-Angle Glaucoma Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Open-Angle Glaucoma Therapeutics Market Size by Country (2019-2024)
6.4 North America Open-Angle Glaucoma Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Open-Angle Glaucoma Therapeutics Market Size (2019-2030)
7.2 Europe Open-Angle Glaucoma Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Open-Angle Glaucoma Therapeutics Market Size by Country (2019-2024)
7.4 Europe Open-Angle Glaucoma Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Open-Angle Glaucoma Therapeutics Market Size (2019-2030)
9.2 Latin America Open-Angle Glaucoma Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Open-Angle Glaucoma Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Open-Angle Glaucoma Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aerie Pharmaceuticals Inc.
11.1.1 Aerie Pharmaceuticals Inc. Company Detail
11.1.2 Aerie Pharmaceuticals Inc. Business Overview
11.1.3 Aerie Pharmaceuticals Inc. Open-Angle Glaucoma Therapeutics Introduction
11.1.4 Aerie Pharmaceuticals Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2019-2024)
11.1.5 Aerie Pharmaceuticals Inc. Recent Development
11.2 Allergan Plc
11.2.1 Allergan Plc Company Detail
11.2.2 Allergan Plc Business Overview
11.2.3 Allergan Plc Open-Angle Glaucoma Therapeutics Introduction
11.2.4 Allergan Plc Revenue in Open-Angle Glaucoma Therapeutics Business (2019-2024)
11.2.5 Allergan Plc Recent Development
11.3 Bausch Health Companies, Inc.
11.3.1 Bausch Health Companies, Inc. Company Detail
11.3.2 Bausch Health Companies, Inc. Business Overview
11.3.3 Bausch Health Companies, Inc. Open-Angle Glaucoma Therapeutics Introduction
11.3.4 Bausch Health Companies, Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2019-2024)
11.3.5 Bausch Health Companies, Inc. Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Detail
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Open-Angle Glaucoma Therapeutics Introduction
11.4.4 Novartis AG Revenue in Open-Angle Glaucoma Therapeutics Business (2019-2024)
11.4.5 Novartis AG Recent Development
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Detail
11.5.2 Pfizer Inc. Business Overview
11.5.3 Pfizer Inc. Open-Angle Glaucoma Therapeutics Introduction
11.5.4 Pfizer Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2019-2024)
11.5.5 Pfizer Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
